Ocugen (MEX:OCGN) 12-1 Month Momentum % : -30.50% (As of Apr. 28, 2025)

View and export this data going back to 2021. Start your Free Trial

What is Ocugen 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2025-04-28), Ocugen's 12-1 Month Momentum % is -30.50%.

The industry rank for Ocugen's 12-1 Month Momentum % or its related term are showing as below:

MEX:OCGN's 12-1 Month Momentum % is ranked worse than
66.02% of 1439 companies
in the Biotechnology industry
Industry Median: -19.06 vs MEX:OCGN: -30.50

Competitive Comparison of Ocugen's 12-1 Month Momentum %

For the Biotechnology subindustry, Ocugen's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ocugen's 12-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ocugen's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Ocugen's 12-1 Month Momentum % falls into.

Save Embed

;

Save Embed

;

Ocugen (MEX:OCGN) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %

( Price 1-month ago

Price 12-month ago

- 1 )

100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ocugen (MEX:OCGN) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.

Ocugen 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Ocugen's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.

Ocugen Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ocugen Inc (MEX:OCGN) » Definitions » 12-1 Month Momentum %

Comparable Companies

Traded in Other Exchanges

OCGN:USA 2H51:Germany

Address

11 Great Valley Parkway, Malvern, PA, USA, 19355

Website

https://www.ocugen.com

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").